Cargando…
An update on pathobiologic roles of anti-glycan antibodies in Guillain-Barré syndrome
Anti-glycan antibodies directed against gangliosides are now considered the major immune effectors that induce damage to intact nerve fibers in some variants of the monophasic neuropathic disorders that comprise Guillain-Barré syndrome. Recent experimental studies elucidating the complexity of anti-...
Autores principales: | Sheikh, Kazim A, Zhang, Gang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948347/ https://www.ncbi.nlm.nih.gov/pubmed/20948812 http://dx.doi.org/10.3410/B2-21 |
Ejemplares similares
-
An Update in Guillain-Barré Syndrome
por: Winer, J. B.
Publicado: (2014) -
Detection of anti-ganglioside antibodies in Guillain-Barré syndrome
por: Zhu, Wenli, et al.
Publicado: (2021) -
Role of Campylobacter jejuni Infection in the Pathogenesis of Guillain-Barré Syndrome: An Update
por: Nyati, Kishan Kumar, et al.
Publicado: (2013) -
Association of anti‐gangliosides antibodies and anti‐CMV antibodies in Guillain–Barré syndrome
por: Wang, Lijuan, et al.
Publicado: (2017) -
Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome
por: Rajabally, Yusuf A.
Publicado: (2022)